TORONTO, Oct 2, 2024—Arrayus Technologies Inc., a leader in innovative medical technology, is pleased to announce that its MRI-guided focused ultrasound system has been granted approval by Health Canada for the ablation of uterine fibroid tissue. Following the success...
— Search Results —
Bracco Imaging S.A. and Arrayus Technologies Announce Agreement to Enhance Drug Delivery for Pancreatic Cancer Treatment Using Focused Ultrasound and Microbubble Technology
TORONTO, Sept. 19, 2024- Bracco Imaging S.A., a global leader in diagnostic imaging, and Arrayus Technologies Inc., a medical device company committed to advancing novel cancer treatments have announced a new agreement. This collaboration will leverage Bracco...
Arrayus Technologies Awarded Funding to Advance Focused Ultrasound Therapy Through AI
TORONTO, Jan. 18, 2023 /CNW/ - Arrayus Technologies Inc., an innovator in focused ultrasound therapy for oncology, announced today it has been awarded funding of up to $1.9 million from INOVAIT and the Government of Canada through the INOVAIT Focus Fund to develop and...
Harmonic Medical announces rebranding as Arrayus Technologies
Press Release— Harmonic Medical, a medical device company developing a multi-modality focused ultrasound platform for non-invasive cancer therapy, is pleased to announce the business’ rebrand to Arrayus Technologies. Coinciding with a new corporate name, the strategic...